REPEATED THERAPEUTIC LEUKAPHERESIS - A SOLE TREATMENT DURING PREGNANCY AS A BRIDGE BEFORE TYROSINE KINASE INHIBITORS FOR A PREGNANT WOMAN WITH CHRONIC MYELOGENOUS LEUKEMIA – A CASE REPORT AND DISCUSSION
Objective: Chronic myelogenous leukemia (CML) is a disease, that in cases with high leukocyte numbers, is treated with hydration and cytoreductive therapy. Materials and Methods:A 20-year-old female patient, during a routine examination for pregnancy, presented with elevated white blood cells (WBC...
Saved in:
Main Authors: | Ivan Tonev, Chavdar Botev, Georgui Balatzenko, Milcho Mincheff |
---|---|
Format: | Article |
Language: | English |
Published: |
Peytchinski Publishing
2025-01-01
|
Series: | Journal of IMAB |
Subjects: | |
Online Access: | https://www.journal-imab-bg.org/issues-2025/issue1/2025vol31-issue1-5985-5988.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical efficacy and safety of first‐line nilotinib or imatinib therapy in patients with chronic myeloid leukemia—Nationwide real life data
by: Petra Belohlavkova, et al.
Published: (2024-09-01) -
Gastrointestinal stromal tumors
by: A. P. Seryakov
Published: (2010-08-01) -
Identification of rare atypical BCR-ABL1 transcript: A case report
by: Jayesh Saha, et al.
Published: (2023-07-01) -
The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia or Philadelphia chromosome‐like acute lymphoblastic leukemia
by: Xiaoxia Wu, et al.
Published: (2024-09-01) -
SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activation
by: Liangying Zhang, et al.
Published: (2025-02-01)